Professional Documents
Culture Documents
Course introduction
Lecture 1: Introduction to Nutrition
Care Process
Course Introduction
• From a basic nutrition (food and nutrients;
sources, functions, deficiencies and excesses),
developmental (nutrition throughout the life
cycle), to applied (nutrition and health;
community nutrition) up to nutrition as a
therapeutic tools for a disease’s management.
• Specialized diets in
MNT may include:
– supplemental nutrition
for pts cannot obtain
adequate nutrients
through food intake
alone
– enteral nutrition
– parenteral nutrition
Cornerways
Hammond KA. Assessment: Dietary and Clinical Data. In Krause, 12th edition, p. 386
1/28/2021 STM4202- NCP:Screening
Prevalence of Nutrition Risk in Acute Care
• The prevalence of nutrition risk will vary depending
on the population screened and the criteria used for
screening.
• In published studies, prevalence of malnutrition in
hospitalized pts ranged from 12% - > 50%.
• There is little published data regarding nutrition
screening for other purposes.
Anthropometric measurements
• Include height, weight, body mass index (BMI), growth
rate, and rate of weight change.
CATEGORIES OF NUTRITION
ASSESSMENT DATA
Nutrition-focused physical findings
• Include oral health, general physical appearance, muscle
and subcutaneous fat wasting
Client history
• Include medication and supplement history, social
history, medical/health history, and personal history.
…CATEGORIES OF NUTRITION
ASSESSMENT DATA
• Determining appropriate data to collect
• Determining the need for additional information
• Selecting assessment tools and procedures that
match the situation
• Applying assessment tools in valid and reliable ways
• Distinguishing relevant from irrelevant data
• Distinguishing important from unimportant data
• Validating the data
Nutrition Care Process Snapshot NCP step 1: Assessment www.eatright.org
Trauma and closed head Increased energy needs r/t multiple trauma as
injury evidenced by results of indirect calorimetry
NUTRITION INTERVENTION
STRATEGIES
• Prioritize nutrition diagnoses
• Consult AND’s EBNPG
• Determine patient-focused expected outcomes
• Confer with family members/caregivers
• Define nutrition plan and strategies
• Define time and frequency of care
DOCUMENTATION OF NUTRITION
INTERVENTIONS
• Critical step that defines the outcomes specific
to nutrition care.
• Overlapping between nutrition assessment,
monitoring and evaluation terminology (except
client history).
• Generating a standardization of evaluating the
effectiveness of nutrition intervention.
• Changes in severity,
duration of disease
NCP EXAMPLE #2
Nutrition Diagnosis
• Involuntary weight loss related to missing meals as
evidenced by loss of 15 lbs over 3 months.
• Inadequate oral food and beverage intake
NCP EXAMPLE #2
Nutrition Intervention
• Diagnosis 1: Involuntary weight loss
• During the hospitalization JW will maintain his current
weight, following discharge he will begin to slowly gain
weight up to a target weight of 145lb.
• JW will modify his diet to include adequate calories and
protein through the use of nutrient-dense foods to prevent
further weight loss and eventually promote weight gain.
NCP EXAMPLE #2
Nutrition Intervention
• Diagnosis 2: Inadequate oral food and beverage intake
• While in the hospital JW will include nutrient-dense foods in
his diet, especially when his appetite is limited.
• Following discharge JW will attend a local senior center for
lunch on a daily basis to help improve his socialization and
caloric intake.
NCP EXAMPLE #2
Monitoring and Evaluation
• Monitoring will include weekly weight measurements and
nutrient intake analyses while he is in the hospital and
biweekly weight measurements at the senior center or clinic
when he is back at home.
• If nutrition status is not improving, such as JW’s weight
records and goals not being met, JW needs to be
reassessed and develop new goals and create plans for new
interventions.
NCP EXAMPLE #2
American Dietetic Association. Frequently Asked Questions Regarding the Nutrition Care
Process and Model (2008). Retrieved November 2, 2009 from www.eatright.org
Bueche, J., Charney, P., Pavlinac, J., Skipper, A., Thompson, E., & Myers, E. (2008). Nutrition
care process and model part I: The 2008 update. Journal of the American Dietetics
Association, 113-117. Retrieved November 13, 2010 from http://www.eatright.org/
HealthProfessionals/content.aspx.?id=7077&terms=NCP
Calhoun, J., Goukasian, C., Siritiranukul, j., & Young, R. Nutrition Care Process. November
2010. Retrieved November 2012
Leidys, L., Louisa, B., & Noura, A., & Star, E. Nutrition Care Process. November 2010.
Retrieved November 2012.
REFERENCES
Mahan, L.K., & Escott-Stump, S. (2008). Krause’s Food & Nutrition Therapy (12th ed.).
Philadelphia: Saunders.
Nutrition Care Process: Diagnosis, Intervention, Evaluation, and Monitoring. Retrieved from
www3.uakron.edu.
Nutrition Care Process Step 4: Nutrition monitoring and evaluation. On-line, International
Dietetics & Nutrition Terminology Reference Manual - Third Edition Retrieved November
13, 2010 from http://www.adancp.com/topic.cfm?ncp_toc_id=1124
Nutrition Diagnosis Snapshot (2009). In Pocket guide for International dietetics & nutrition
terminology (IDNT) reference manual (pp. 137-141). Chicago, IL: ADA
Nutrition Diagnosis Snapshot (2010). In Pocket guide for International dietetics & nutrition
terminology (IDNT) reference manual, ed. 3rd. (pp. 313- 314). Chicago, IL: ADA
REFERENCES
THANK YOU!
NOVEMBER 21, 2012
Documentation of Nutrition Care
Nutritional Care Record
• Written documentation of the nutritional
care process, including the interventions
and activities used to meet the nutritional
objectives
• “If it’s not documented, it didn’t happen.”
• Written as part of the Medical record
Nutrition Care Documentation
1. Quality assurance
2. Communication
1. Health care team
2. Verifies care given
3. Peer review
4. State audits
Documentation Styles
• ADIME (assessment, diagnosis, intervention,
monitoring and evaluation)
• DAP (diagnosis, assessment, plan)
• DAR (data, action, response)
• PIE (problem, intervention, evaluation)
• PES (problem, etiology, symptoms)
• IER (intervention, evaluation, revision)
• HOAP (history, observation, assessment, plan)
• SAP (screen, assess, plan)
• SOAPIER (subjective, objective,
analysis/assessment, plan, intervention, evaluation,
revisions)
• SOAP (subjective, objective, assessment, plan)
SOAP Notes
S: Subjective
• Info provided by patient, family, or other
• Pertinent socioeconomic, cultural info
• Level of physical activity
• Significant nutritional history: usual eating
pattern, cooking, dining out
• Work schedule
SOAP Notes—cont’d
O: Objective
• Factual, reproducible observations
• Diagnosis
• Height, age, weight—and weight gain/loss
patterns
• Lab data
• Clinical data (nausea, diarrhea)
• Diet order
• Medications
• Estimation of nutritional needs
SOAP Notes—cont’d
A: Assessment
• Nutrition diagnosis
• Interpretation of patient’s status based on
subjective and objective info
• Evaluation of nutritional history
• Assessment of laboratory data and
medications
• Assessment of diet order
• Assessment of patient’s comprehension and
motivation
SOAP Notes—cont’d
P: Plan
• Diagnostic studies needed
• Further workup, data needed
• Medical nutrition therapy goals
• Education plans
• Recommendations for nutritional care
SOAP EXAMPLE
• S: Patient works night shift, eats two meals a day, before
and after his shift; fried foods, burgers, ice cream, beers
in restaurants. Does not add salt to foods. Activity: Plays
golf 1x month.
• O: 34 y.o. male s/p MI with history of htn, DM2,
hyperlipidemia.
• Ht: 5 ft. 10 in; wt: 250 lb; BMI 36, Obesity II
• A: Excessive sodium intake (NI-5.10.2) related to
frequent use of vending foods as evidenced by diet
history. Pt could benefit from increased activity and
gradual wt loss as recovery allows
• P: Provided basic education (E-1) on 3-4 gram sodium
diet and wt management guidelines
• Patient will return to outpatient nutrition clinic for
lifestyle intervention and counseling (C-2.1).
Pros and Cons of SOAP Charting
PROS CONS
• Common use by nutrition • Tends to encourage
care professionals and lengthy chart notes
other disciplines • One study suggests
• Taught in most dietetics physicians are less likely
education programs to respond to this format
• Easy to learn and utilize than others*
• Downplays evaluation
• Emphasizes legitimacy of
objective over subjective
data
*Skipper A, Young M, Rotman N, Nagl H. Physicians’ implementation of dietitians’
recommendations: a study of the effectiveness of dietitians. J Am Diet Assoc 1994;94:45-49.
ADIME
Developed to facilitate the NCP
• A – Assessment
• D – Diagnosis
• I – Intervention
• M – Monitoring
• E - Evaluation
Assessment (A)
• All data pertinent to clinical decision
making, including diet history, medical
history, medications, physical assessment,
lab values, current diet order, estimated
nutritional needs
• Should include relevant data only
Diagnosis
• Should include PES statement for nutrition
diagnosis
• Patients may have more than one diagnosis,
but try to choose the one or two most
pertinent, or the ones you mean to address
Intervention
• What do you recommend or plan to do to
address the nutrition diagnoses?
• Recommend change in food-nutrient
delivery (supplement, change in diet,
nutrition support, vitamin-mineral
supplement) (NI)
• Nutrition education (E)
• Nutrition counseling (C)
• Coordination of nutrition care (RC)
Monitoring and Evaluation (ME)
• What will you monitor to determine if the
nutrition intervention was successful?
• Generally based on the signs and symptoms
• Weight
• Intake
• Lab values
• Clinical symptoms
Example of ADIME
• A - 34 y.o. male s/p MI with history of htn, DM2,
hyperlipidemia; ht: 5 ft. 10 in; wt: 250 lb; BMI 36,
obesity II. Patient works night shift, eats two
meals a day, before and after his shift--fried foods,
burgers, ice cream, beers in restaurants.. Does not
add salt to foods. Activity: Plays golf 1x month.
• D - Excessive energy intake (NI-1.5); excessive
sodium intake (NI-5.10.2) related to frequent use
of restaurant foods as evidenced by diet history.
Example of ADIME
• I – Provided basic education (E-1) on 3-4 gram
sodium diet and wt. management guidelines
(nutrition education); pt to return to outpatient
nutrition clinic for lifestyle intervention (C-2.1)
• ME – Evaluate weight (S-1.1.4), blood pressure
(S-3.1.7), diet history at outpatient visit sodium
intake (FI-6.2); energy intake (FI1.1.1); fat intake
(FI-5.1.1) Re-check lipids in 3 months (S-2.6)
Narrative Note
• Brief summary of progress, data, action in
a paragraph format
• Frequently used to document brief
interventions or follow-ups to initial
assessments
• Nutrition professionals may use for same
purpose or to document food preference
interviews, response to a patient question or
complaint, re-screening of low risk pts
Brief Narrative Note Example
34 y.o. male s/p MI with history of htn, DM2,
hyperlipidemia. Ht: 5 ft. 10 in; wt: 250 lb
Patient works night shift, eats two meals a day,
before and after his shift, fried foods, burgers,
ice cream, beers in restaurants. Does not add salt
to foods.
Nutrition diagnosis: Excessive energy intake
(NI-1.5) related to high intake of fat and
restaurant foods aeb BMI and diet history.
Response (Evaluation) Pt was able to list high
sodium foods and appropriate diet changes (BE-
2.2.1)
Electronic Medical Record
• Many health care institutions are
implementing electronic medical records
(Aultman and Mercy Medical Center)
• All disciplines can access the patient chart
concurrently
• Entries are more legible, making errors less
likely
• Data can be organized to support clinical
decision making
Revision
STM 3202 (Pemakanan Sepanjang Hayat)
2 servings
3 servings
1 servings
1 servings
1/2 servings
2 servings
Based on
2000 kcal/day
Based on
1500 kcal/day
Figure 3: Sample menu
1. Calculate the number of servings
according to each food groups below:
@ 10-20% of TEI
Meals Menu
Breakfast
Morning Tea
Lunch
Afternoon
snack
Dinner
Supper
Based on
1500 kcal/day
STM4201 Lecture 5:
Hospital diets and Dietary Guidelines
1/29/2021 1
Hospital diets: Diet modifications
- Therapeutic diets are based on normal diet.
- The purpose is to supply the required nutrients in the form
that the body can handle.
- Therefore, to prepare & evaluate the diets, knowledge of
nutrient composition is necessary.
- Changes involved:
1) consistency: liquid diet, soft diet
2) energy value: wt reduction diet, ↑ cal diet
3) type of food/ nutrient consumed: sodium/
lactose-restricted diet, low/high-fiber/potassium diet.
4) elimination of specific food: allergy diet,
gluten/lactose-free diet.
1/29/2021 STM 4201 Standard hospital diet 2
& SOAP
Changes involved (cont)..
5) adjustment in level, ratio, or balance of protein, fat and CHO
E.g.- diet for diabetic, ketogenic-, renal- and chol-lowering diet
- Used for pt who are unable to chew, swallow or digest solid foods.
- A transition between a clear liquid diet and a regular diet
What Is Purine?
Purine is a compound found mostly in
foods that come from animals. It is very
high in organ meats, anchovies, mackerel,
and sardines.
1/29/2021 29
Key message 4: Eat adequate amount of rice,
other cereal products (preferably whole grain) and
tubers
• Consume at least 4 servings of cereal foods daily
• Choose at least half of your grain products from whole grains
• Choose cereal products that are high in fibre, low in fat, sugar
and salt
1/29/2021 30
Key message 5: Eat plenty of fruits and
vegetables everyday
• Eat a variety of fruits everyday
• Eat a variety of vegetables everyday
• Eat at least 5 servings of fruits and vegetables
everyday
1/29/2021 31
Key message 6: Consume moderate amounts of
fish, poultry, egg, legumes and nuts
• Consume fish more frequently, if possible everyday
• Consume meat, poultry and egg moderately
• Practise healthier cooking methods for fish, meat poultry
and egg dishes
• Choose meat and poultry that are low in fat and cholesterol
• Consume legumes daily
• Include nuts and seeds weekly diet
1/29/2021 36
Key message 10: Consume foods and beverages
low in sugar
• Eat foods low in sugar
• Drink beverages low in sugar
Vs.
1/29/2021 40
Key message 14: Make effective use of nutrition
information on food labels
• Use Nutrition Information
panel (NIP) as a guide in
making food choices
• Make use of nutrition claims
wisely
• Educate children on the use
of NIP
BE REALISTIC BE SENSIBLE
Make small changes overtime in Enjoy all foods, just don’t over do
what you eat and the level of activity it
you do. After all, small changes
work better than giant leaps
BE ADVENTUROUS BE ACTIVE
Expand your tastes to enjoy Walk the dog,
a variety of foods don’t just watch the dog walk
BE FLEXIBLE
Balance what you eat and the physical activity
you do over several days. No need to worry about
just one meal or one day
1/29/2021 STM 4201 Standard hospital diet 42
& SOAP
Upper Gastrointestinal
Disorders
Upper GI Anatomy
Nausea & Vomiting
Pathophysiology
• Small meals
• Beverages between meals
• Dry, starchy foods or cold/room
temperature foods may be better
tolerated
• Fatty, spicy, strong-smelling, or hot
foods may be less tolerated
Gastroesophageal Reflux
Disease - GERD
Pathophysiology
✓Reflux esophagitis
(inflammation in the esophagus related
to the reflux of acidic stomach contents).
✓Esophageal ulcers
✓Scarring of ulcerated tissue
(continues)
Medical nutrition therapy
of Hiatal Hernia
✓Small, frequent meals of well-balanced
diet
✓Avoid irritants to esophagus
✓Avoid foods that relax lower esophageal
sphincter
✓Weight loss recommended if necessary
✓Avoid lying down two to three hours
after eating
Gastritis
✓Acute cases
• Caused by irritating substances or treatments that
damage the gastric mucosa (alcohol, chemotherapy,
ingestion of toxins or corrosive materials)
✓Chronic cases
• Caused by long-term infections: Helicobacter pylori
• Autoimmune disease
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
Complications
– Partial gastrectomy
• Only part of the stomach is removed
• Remaining portion is connected to the
duodenum or jejunum
– Total gastrectomy
• Entire stomach removed
• Esophagus connected directly to the small
intestine
Post Gastrectomy Diet
Malabsorption, steatorrhea
• genetic predisposition
• abnormally high secretion of
hydrochloric acid by the stomach
Signs and symptoms of Peptic
Ulcer
✓ GI bleeding
(black stool- vomit that
resembles coffee ground)
✓ Perforations of the stomach
or duodenum leading directly
into the peritoneal cavity
✓ Gastric outlet obstruction
due to inflammation
Drug therapy for Peptic Ulcer
1. Drugs that suppresses acid secretion by
inhibiting receptors on acid-producing
cells
2. Antacids
3. Coating agents
4. Antibiotics to eradicate H.pylori
Dietary considerations for peptic
ulcer
Digestion
Begins in mouth & stomach
Continues in duodenum & jejunum
Secretions:
Liver
Pancreas
Small intestine
Dietary modifications:
To alleviate symptoms
Correct nutritional deficiencies
Address primary problem
Must be individualized
Causes- systemic
Side effect of medication
Metabolic endocrine abnormalities
Lack of exercise, chronic use of laxative
Ignoring the urge to defecate
Vascular disease of the large bowel
Systemic neuromuscular disease
Poor diet, low in fiber, inadequate fluid intake, milk intake
Pregnancy, anxiety, travel
1/30/2021 8
Causes of Constipation - Gastrointestinal
Diseases of the upper GIT
Celiac Disease
Duodenal ulcer
Diseases of the large bowel resulting in:
Failure of propulsion along the colon
Failure of passage though anorectal
structures
Irritable bowel syndrome (IBS)
Hemorrhoids
Laxative abuse
1/30/2021
Copyright STM4201-
© 2000 by W. B. Saunders Company. All rightsMNT for Lower GIT
reserved. 9
Diagnostic Tests Constipation
Begins with a physical exam including a digital rectal
exam. Other tests:
Thyroid tests
Barium enema x-ray: colonic contrast study
Sigmoidoscopy
Colonoscopy
Colorectal transit study
Anorectal manometry tests
Evacuation proctography
High-fibers Diet
Most Americans/ people = 10 – 15 g/day
Recommended = 25 g/day 0r 14 g/1000 kcal
More than 50g/day = no added benefit,
may cause problems
Etiology
Inflammatory disease
Infections
Medications
Overconsumption of sugars
Insufficient or damaged mucosal absorptive surface
Malnutrition
Should identify and treat the underlying problem
Used in:
Maldigestion
Malabsorption
Diarrhea
Temporarily after some surgeries, e.g. hemorrhoidectomy
Pancreatic insufficiency
Inadequate reabsorption of bile salt
↓ fat re-esterification & formation and transport of
chylomicrons
Celiac disease
Pattern of symptoms
Delete gluten sources from diet (wheat- gliadin, rye- secalin, barley-
hardein, oats- avenin)
Pts should see a dietitian who is familiar with this disease and its
treatment
1/30/2021 STM4201- MNT for Lower GIT 40
Celiac Disease
Read labels carefully for problem ingredients
Even trace amounts of gliadin are problematic
Common problem additives include fillers,
thickeners, seasonings, sauces, gravies, coatings,
vegetable protein
Genetic form
Lactase deficiency
Sac-like herniations or
outpouches of the
colon wall
Caused by long-term
increased colonic
pressures
Believed to result from
low fiber diet,
constipation
=
CHO counting
• Carb counting
helps people
with diabetes
plan their
meals and
snacks
• 1 serving of
food with
CHO = 15
grams of
CHO.
MNT TYPE 2 DM
2nd Ed (2013)
◼ ↓ LDL cholesterol up to 7%
1 drink
Should be taken with
= 15 g alcohol meals to prevent hypoglycemia
-alcohol blocks gluconeogenesis
= 360 ml beer & increase effects of insulin
= 150 ml wine
= 45 ml hard liquor / distilled spirits
◼ Aspartame (NutraSweet®)
◼ Acesulfame potassium,
acesulfame-K (Sweet One®)
◼ Sucralose (SPLENDA®)
1/30/2021 STM 4201 MNT for Diabetes 50
“STAGES” OF TYPE 2 DIABETES
LIFESTYLE
MONOTHERAPY
100
%
COMBINATION
THERAPY
b-CELL
FUNCTION REQUIRE
INSULIN
UKPDS: “HOMA”
ANALYSIS IGT PP DM DM DM
BS “1” “2” “3”
-10 -5 0 5 10
YEARS FROM DIAGNOSIS
1/30/2021 STM 4201 MNT for Diabetes 52
Source
◼ Further divided:
1/30/2021 61
Macronutrients Based On:
◼ Pt goals
Caution: Choose:
◼ Very strenuous ◼ Moderate activity
activity such as walking,
◼ Heavy lifting or swimming, biking,
straining gardening
◼ Exercise in extreme ◼ Moderate lifting,
cold or heat stretching
Caution Choose
◼ Very strenuous ◼ Moderate activity
activity like:
◼ Heavy lifting or – walking
straining – weight lifting
with light weights
– stretching
Caution Choose
◼ Strenuous exercise ◼ Moderate, low-impact
◼ Heavy lifting and activities:
straining – walking
◼ High-impact aerobics, – cycling
jogging – water exercise
◼ Bending your head ◼ Moderate daily chores
below your waist – toe that don’t require
touching lifting or bending your
head below your waist
1/30/2021 STM 4201 MNT for Diabetes 76
Exercising with Nephropathy
(kidney disease)
Caution Choose
◼ Strenuous ◼ Light to moderate
activity activity like walking,
light housework,
gardening, water
exercise
Exercise is known to temporarily increase
**
protein excretion
1/30/2021 STM 4201 MNT for Diabetes 77
Exercising with Neuropathy
(nerve disease)
Caution Choose
◼ Weight-bearing, high ◼ Low impact, moderate
impact, strenuous, or activities:
prolonged exercise: – biking
– jogging/running – swimming
– step exercise – chair exercises
– jumping – stretching
– light to moderate
– exercise in heat/cold daily activities
Check feet after exercise 78
Exercise Safely
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Cardiovascular Disease (CVD)
The leading cause of death in the world.
Includes deaths from coronary heart disease
(CHD) and stroke.
1/3 of deaths occur before age 65.
Risk reduction; major breakthroughs in prevention
and treatment.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Cardiovascular Disease (cont)
In Malaysia, CHD deaths reached 22,701 (22.2%).
Malaysia total deaths by cause:
– 1. CHD
– 2. Stroke (11.7%)
– 3. Influenza & pneumonia (9.2%)
– 4. Road traffic accidents (7.9%)
– 5. HIV/AIDS (5.5%)
– 6. TB (4%)
– 7. Lung cancers (3.2%)
– 8. DM (3.1%)
– 9. Lung disease (2.8%)
– 10. Kidney disease (2.5%)
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Coronary Heart Disease/ Coronary Artery Disease
Disease involving the network of blood vessels
surrounding and serving the heart.
Manifested in clinical end points of myocardial
infarction (MI) and sudden death.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Cardiovascular Risk Factors
Markers in Blood
Lipoprotein profile
Low-density–lipoprotein cholesterol
Total triglycerides
High-density–lipoprotein cholesterol
Inflammatory Markers
Fibrinogen
C-Reactive protein
Lifestyle Risk Factors
Tobacco
Physical inactivity
Poor diet
Stress
Excessive alcohol consumption
Related Diseases/ Syndrome
Hypertension
Diabetes
Obesity
Metabolic syndrome
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Highlights of the Framingham Study:
Most Significant Milestones
1960 Smoking the risk of heart disease
1961 Cholesterol level, BP and electrocardiogram
abnormalities risk of HD
1967 Physical activity found to reduce risk, obesity risk
of HD
1970 High BP risk of stroke
1976 Menopause risk
1978 Psychosocial factors found to affect HD
1988 High [HDL-c] to reduce risk of death
1996 Progression from HTN to heart failure described
2006 Beginning of the genetic research study
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Major Disease Processes Contributing to CHD
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Natural Progression of Atherosclerosis
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Pathophysiologic Steps in Development of CHD/ MI
Phase 1 Fatty streaks (atherogenesis)
Phase 2 Atheroma (or plaque) formation
Phase 3 Complicated lesions with
rupture (nonocclusive
thrombosis)
Phase 4 Complicated lesions with
rupture and occlusive
thrombosis
Phase 5 Fibrosis (occlusive) lesions
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Much more than simple accumulation of lipids within the artery wall; it is
a complex inflammatory response to tissue damage
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Blood Lipids and Lipoproteins
Total cholesterol: amount in all lipoprotein
fractions
Total triglyceride: hypertriglyceridemia
Chylomicrons: transport dietary fat and
cholesterol from small intestine to liver and
periphery
VLDL: transport endogenous triglyceride and
cholesterol
LDL: major cholesterol transport lipoprotein
HDL: reverse cholesterol transport
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Genetic Hyperlipidemias
Familial hypercholesterolemia
Polygenic familial hypercholesterolemia
Familial combined hyperlipidemia
Familial dysbetalipoproteinemia
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Hyperlipidemias
Elevated blood TG and/or chol
Lipoproteins found in blood
Chylomicrons = postprandial dietary fat, transport
of dietary TG
VLDL= lipid being transported from liver to
peripheral tissue, transport of endogenous TG
LDL= transport of cholesterol, major cholesterol
transport lipoprotein
HDL= reverse transport of cholesterol, tissues to
liver
Type of hyperlipidemia depends upon portion of
particles present
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Prevention of CHD and Stroke
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Assessing Risk
Counting risk factors and using algorithms
Very high risk, high risk, moderate risk, low
risk
Imaging tools
National Screening for Heart Attack
Prevention and Education (SHAPE)
Program
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Blood Markers for CHD
Lipoprotein profile
– Total cholesterol >200 mg/dl (5.2 mmol/L)
– LDL cholesterol >130 mg/dl (3.4 mmol/L)
– HDL cholesterol <40 mg/dl (1.04 mmol/L)
– Triglycerides >150 mg/dl (1.7 mmol/L)
Inflammatory markers
– Fibrinogen
– C-reactive protein
– Homocysteine
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Lipoprotein Assessment
Includes measurement of fasting TC, LDL-c,
HDL-c, and TG level
Classification of serum TG
<150 (mg/dL)
Normal
or < 1.7 (mmol/L)
150-199
Borderline High
or 1.7-2.3
200-499
High
or 2.3-5.6
>500
Very High
Or > 5.5
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Factors associated with elevated TG’s
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
LDL CHOLESTEROL
<100 mg/dL or < Optimal
2.6 mmol/L
100-129 or 2.6-3.4 Near optimal/above optimal
160-189 or High
4.1-4.9
190/4.9 Very high
TOTAL CHOLESTEROL
<200/5.2 Desirable
200-239/5.2- 6.2 Borderline high
240/6.2 High
HDL CHOLESTEROL
<40/ 1.04 Low
>60/Elsevier
1.6items and derived items © 2008,High (negates
2004 by Saunders, a risk
an imprint of Elsevier Inc. factor)
LDL and HDL-c
Laboratory Values Predict Risk of CHD
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
HDL-c Levels Predict Risk of CHD
Increased by: Exercise
Wt loss
Moderation of alcohol
Increased by:
Fat in diet
Obesity
Genetic
Infection- Chlamydia pneumonia, H.pylori
Diabetes-
insulin resistance
Hypothyroidism
Decreased by:
Estrogen
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Level to
LDL Initiate Consider Drug
Risk Category
Goal Lifestyle Therapy
Changes
<130 10 yr risk>10%:
2+Risk factors mg/dL
>130 mg/dL
160 mg/dL
<160
190 mg/dL or 4.9
0-1 Risk factor mg/dL or 160 mg/Dl
mmol/L
4.1
Elsevier items and mmol/L
derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
What causes heart disease
Smoking
chol
80% of coronary deaths in France
BP
Diabetes
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Factors that place someone “at risk” for
heart disease
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Factors that place someone “at risk” for
heart disease (cont)
– High BP
– Dyslipidemia
– Evidence of coronary calcification
– Metabolic syndrome
– Poor exercise capacity on a treadmill test
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Calculating
CHD risk for
men
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Modifiable Risk Factors for CHD
Physical inactivity
Obesity
High LDL-c (>100 with CHD, >130 without CHD)
Low HDL-c (<40)
Diabetes
HTN (>140/90)
Smoking
(High Blood Homocysteine)
(C-reactive protein)
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Physical Activity
risk of developing NIDDM by 6% for each 500-kcal/wk
expended
mortality in people with NIDDM; morbidity and
mortality in o’wt individuals even if they remain o’wt
Unfit men who become fit may reduce CVD mortality by
52% compared to those who remain unfit.
Recommendation is for 30 minutes of moderate activity
most days
HDL- and LDL-c
BP up to 10/8 mmHg in hypertensive pts
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Weight Control
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
High cholesterol/ fat
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Current status on cholesterol/ SFA and
blood cholesterol
Diet-heart hypothesis (eating chol & SFA raises blood
cholesterol) originated from studies more than half
a century ago.
– 75% cholesterol is produced in the body
– 25% cholesterol from diet can’t be absorbed by
the body
Based on systematic review (Gazziano & Djousse, 2009)
it was found that the relation between dietary
cholesterol and the risk of CHD is not clearly
understood.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Diet and Prevention of CVD: Lipid
hypothesis
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
The problem with “Lipid hypothesis”
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
The problem with “Lipid hypothesis”
There is no linear relation between cholesterol
levels and heart attack or stroke risk.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
“Lipid hypothesis” of heart disease
First proposed by Russian researcher David Kritchevsky in
1954, later by Ancel Keys.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Inverse associations of SFA intake with mortality from total stroke,
intraparenchymal hemorrhage and ischemic stroke. No associations
between SFA and mortality from subarachnoid hemorrhage and heart
disease.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Intake of SFA was not associated with an increased risk of CHD, stroke
or CVD. Thus no significant evidence to conclude that dietary SFA is
associated with an increased risk of CHD or CVD events.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
LCD were associated with significant decreases in body wt, TG, fasting
glucose, BP, BMI,… and an increase in HDL-c.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
High blood pressure
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Diseases and Syndromes
Related to CVD
Hypertension
Diabetes
Obesity (especially abdominal obesity)
Metabolic syndrome
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Non-modifiable Risk Factors
Menopausal status
Age
Family history
Gender
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
DASH diet
http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Dairy products, such as cheese, do not exert the negative effects on blood
lipids as predicted solely by the content of saturated fat. Calcium and
other bioactive components may modify the effects on LDL-c and
triglycerides… The consumption of yogurt, and other dairy products, in
observational studies is associated with a reduced risk of weight gain and
obesity as well as of CVD..
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
There is abundant evidence that a reduction in dietary sodium and
increase in potassium intake decreases BP, incidence of HTN, and
morbidity and mortality from CVD. However, there is no credible
evidence that existing policies have been effective in achieving
population goals for dietary sodium and potassium intake
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
AHA 2006 Diet Recommendations for
CVD Risk Reduction
• Balance calorie intake and physical activity to achieve or maintain a
healthy body weight.
• Consume a diet rich in vegetables and fruits.
• Choose whole grain, high-fiber foods.
• Consume fish, especially oily fish, at least twice a week.
• Limit intake of saturated fat to <7% of energy, trans-fat to <1% of
energy, and cholesterol to <300 mg/day by:
– Choosing lean meats and vegetable alternatives.
– Selecting fat-free (skim), 1%-fat, and low-fat dairy products.
– Minimizing intake of partially hydrogenated fats.
• Minimize your intake of beverages and foods with added sugars.
• Choose and prepare foods with little or no salt.
• When consuming alcohol, do so in moderation.
• When eating food that is prepared outside of the home, follow the
AHA Diet and Lifestyle Recommendations.
Modified from Lichtenstein AH et al: Diet and lifestyle recommendations revision 2006: a scientific statement from
the American Heart Association Committee, Circulation 114:83, 2006.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Nutrient Composition of the TLC
Dietary Pattern
Nutrient Recommended Intake
Saturated fat* Less than 7% of total calories
Polyunsaturated fat Up to 10% of total calories
Monounsaturated fat Up to 20% of total calories
Total fat 25%-35% of total calories
Carbohydrate† 50% to 60% of total calories
Fiber 25-30 g/day
Protein Approximately 15% of total calories
Cholesterol Less than 200 mg/day
Total calories (energy) Balance energy intake and expenditure to maintain
‡ desirable body weight/prevent weight gain
From National Heart, Lung, and Blood Institute: Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment
panel III), Final report, U.S. Department Of Health and Human Services, NIH Publication No. 02-5215, Bethesda, Md, September 2002.
*Trans-fatty acids are another low-density–lipoprotein raising fat that should be kept at a low intake.
†Carbohydrate should be derived predominantly from foods rich in complex carbohydrates, including grains, especially whole gr ains, fruits,
and vegetables.
‡Daily energy expenditure should include at least moderate physical activity (contributing approximately 200 kcal/day).
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Therapeutic Lifestyle Changes
Nutrient Composition of TLC Diet
Nutrient Recommended Intake
Saturated fat < 7% of total calories
Polyunsaturated fat Up to 10% of total calories
Monounsaturated fat Up to 20% of total calories
Total fat 25–35% of total calories
Carbohydrate 50–60% of total calories
Fiber 20–30 grams per day
Protein Approximately 15% of total calories
Cholesterol Less than 200 mg/day
Total calories (energy) Balance energy intake and expenditure
to maintain desirable body weight/
prevent weight gain
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Step I and II Diets
The AHA and NCEP have developed these
diets to treat BP & hypercholesterolemia
Designed to lower LDL levels, while at the
same time promoting good nutrition.
The AHA no longer use these diets and
recommend the TLC (from ATP III) diet.
ATP III continues to recommend the Step I
diet for the general public.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Step I Step II
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Therapeutic Lifestyle Changes
ATP III TLC dietary pattern
AHA recommendations
– SFA <7% kcal, total fat 25-35% kcal, low
trans-fatty acids
First Visit
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Steps in Therapeutic Lifestyle Changes (TLC) (continued)
Second Visit
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Steps in Therapeutic Lifestyle Changes (TLC) (continued)
Third Visit
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Dietary Factors
Fat
Saturated fatty acids
Monounsaturated fatty acids
– Trans fatty acids
Polyunsaturated fatty acids
Omega-3 fatty acids
Amount of dietary fat
Dietary cholesterol
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
The quality of dietary oils and fats has been widely recognised to be
linked to the pathogenesis of CVD. Prolonged consumption of the
repeatedly heated oil has been shown to increase BP and TC, cause
vascular inflammation as well as vascular changes which predispose to
atherosclerosis..
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
In general, treatment with EPA+DHA appears to lower patient
triglycerides more effectively, but in those patients with very high
triglyceride levels, use of EPA+DHA also raised low-density lipoprotein
cholesterol levels, whereas EPA alone did not. Both formulations, at
doses that do not lower triglycerides, have been shown to reduce CVD
events in some, but not all, studies.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
While the majority of former studies showed a benefit of n-3 FA acid
intake, recent clinical trials using n-3 supplements on top of established
medication and prudent nutrition did not confirm these findings…..The
most recent meta-analyses observed clear benefits of fish consumption,
but not of n-3 capsules intake.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Dietary Factors–cont’d
Fiber
Antioxidants
Soy protein
Stanols and sterols
Weight loss
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Effect of diet on CV deaths
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Primary Prevention with Lipoprotein Analysis
(From National Cholesterol Education Program: Second Report of the Expert Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults (Adult Treatment Panel II). National Institutes of Health, NIH Publication No. 93-3095. Bethesda,
MD: National Heart, Lung, and Blood Institute, 1993.)
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Primary Prevention in Adults without Evidence of CHD:
Initial Classification Based on TC and HDL-c
(From National Cholesterol Education Program: Second Report of the Expert Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults (Adult Treatment Panel II). National Institutes of Health, NIH Publication No. 93-3095. Bethesda,
MD: National Heart, Lung, and Blood Institute, 1993.) HDL = high-density lipoprotein.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
2007 Lifestyle guidelines for prevention of
CVD in Women
Do not smoke
Physical activity
– A minimum of 30 minutes of moderate intensity
activity (brisk walking) on most, preferably all
days of the week
– For wt loss or maintenance: 60-90 minutes of
moderate intensity activity on most, preferably
all days of the week
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
2007 Lifestyle guidelines for prevention of
CVD in Women (cont)
Consume a diet rich in:
– Fruits and vegetables
– Whole grains
– High fiber foods
Consume fish, especially fatty fish at least
2x/wk (source of n-3 fatty acids)
Women with heart disease, MAY want to
consider n-3 supplementation of 850-1000
mg/day
Consider screening women with CHD for
depression and treat when appropriate
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
2007 Guidelines for prevention of CVD
in Women
Limit SFA to <7% of calories (15-20 g/day)
Limit cholesterol intake to < 200 mg/day
Reduce sodium intake to < 2300 mg/day
Achieve and maintain an appropriate wt
through healthy behavior changes (physical
activity, calorie intake, and formal behavior
programs if indicated)
Manage diabetes, blood lipids and high BP
aggressively
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Saturated Fat
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Inflammatory eicosanoid precursors
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Pro- and anti-inflammatory action of n-
3 PUFAs
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Possible mechanism…
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Ineffective or potentially harmful
interventions
Hormone therapy to prevent or treat CVD
Use of anti-oxidant supplements (Vit E, C,
beta carotene) to prevent or treat CVD
Folic acid
Routine use of aspirin (in healthy women
under 65 years of age)
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Treatment with HT in post-menopausal women for either primary or
secondary prevention of CVD events is not effective, and causes an
increase in the risk of stroke, and venous thromboembolic events. Short-
term HT treatment should be at the lowest effective dose, and used with
caution in women with predisposing risk factors for CVD events.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Results from large randomized controlled trials did not support long-
term use of single antioxidant supplements for CVD prevention due
to their null or even adverse effects on major cardiovascular events or
cancer. Diet quality indexes that consider overall diet quality rather than
single nutrients have been drawing increasing attention. Cohort studies
and intervention studies that focused on diet patterns such as high total
antioxidant capacity have documented protective effects on CVD risk.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Limited evidence supports any benefit from vitamin and mineral
supplementation for the prevention of cancer or CVD. Two trials found a
small, borderline-significant benefit from multivitamin supplements on
cancer in men only and no effect on CVD.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
The efficacy of aspirin for secondary prevention of cardiovascular
disease is well established, but the clinical benefit of aspirin for
primary prevention of CVD is less clear. The primary literature
suggests that aspirin may provide a reduction in CVD events, but the
absolute benefit is small and accompanied by an increase in bleeding.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Clinical identification of Metabolic Syndrome (any
3 of the following)
Risk Factor Defining level
Abdominal Obesity Waist Circumference
Men >102 cm(>40”)
Women >88 cm (>35”)
Triglycerides 150 mg/dL
HDL Cholesterol
Men <40 mg/dL
Women
<50 mg/dL
Blood Pressure 130/ 85 mmHg
Fasting Glucose 110mg/dL
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Quantity of Soluble Fiber Needed Daily to
Produce Lipid-Lowering Effect
Pectin: 6 - 40 g
Gums: 8 - 36 g
Dried beans or legumes: 100 - 150 g
Dry oat bran: 25 - 100 g
Oatmeal: 57 - 140 g
Psyllium: 10 - 30 g
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
General Goals for Treatment
of Hyperlipidemias
Achieve IBW.
Decrease simple sugars and alcohol.
Decrease total fat, especially chol and SFA.
Increase complex CHO and fiber.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Pharmacologic Management
Diet is still important to minimize need for drugs
After a 6-month trial on each diet, drugs are
added to the treatment.
Types
– Bile acid sequestrants (e.g., cholestyramine)
– Nicotinic acid
– HMG CoA reductase inhibitors (statins) (e.g.,
lovastatin, pravastatin)
– Fibric acid derivatives (e.g. clofibrate,
gemfibrozil)
– Probucol
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Medical Intervention
Percutaneous coronary intervention (PCI)
Coronary artery bypass graft (CABG)
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
MI- Coronary Infarction, Coronary Thrombosis,
or Heart Attack
Some part of coronary circulation blocked
Ischemia leads to muscle destruction
Diagnosis: ECG; blood levels of enzymes
such as LDH and CPK
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Myocardial Infarction (MI)
Post-infarction nutrition
1. 1st 24 hrs: no caffeine, liquid diet
(nausea and choking are common)
2. Small frequent meals; soft or liquid diet
3. Na+ restriction if BP and fluid status indicate
4. Consistent diet information
5. Drugs that cause nausea- digitalis, morphine
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Summary/ Focal Points
Lifestyle changes, MNT at the cornerstone, are pivotal to
maintaining cardiovascular health.
In the past the focus has been on lipid lowering; however,
more research is uncovering the role of diet in inflammation
and endothelial dysfunction, which are involved in
atherogenesis.
LDL-c levels are the primary target for medical nutrition
therapy.
The AHA, TLCs, and DASH dietary patterns are
recommended in both the primary and secondary prevention
of CVD.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Lecture 11 STM 4201
Medical Nutrition Therapy for Renal
Disorders
.
Video
◼ https://www.youtube.com/watch?v=E1myFSlpy-A
(1st Video - CKD)
◼ https://www.youtube.com/watch?v=LtdWg4ygm_E
&t=223s
(2nd Video – Diabetic Nephropathy)
◼ https://www.youtube.com/watch?v=mi34xCfmLhw
(3rd Video – Failing Kidney Tx Options)
Group Discussion
◼ Form a group of 3 members
◼ Assign to each member (1 person – 1 video)
◼ Discuss the topic with 3 persons who were
assigned with similar video.
◼ Return to your earlier group and explain
your topic to your group members.
◼ Summarize the 3 topics in a mind map
(1 group – 1 mind map)
◼ Post your group’s mind map in e-learning
(CKD Forum)
Functions of the Kidney
Excretory
Acid-base balance
Endocrine
Fluid and electrolyte balance
2/1/2021
. STM4201 MNT for renal disorders 4
The Most Common Kidney Diseases
Glomerulonephritis
Glomerulosclerosis
Nephrotic syndrome
Diabetic Nephropathy
End-Stage Renal
2/1/2021
. STM4201 MNT for renal disorders 5
Primary Renal Disease
2/1/2021
. STM4201 MNT for renal disorders 6
The Most Common Kidney Diseases
Glomerulonephritis- Inflammation or damage of
glomeruli / membrane tissue; nephritic syndrome.
Causes of damage other than infections: acute interstitial
nephritis, associated with use of creatine supplement.
– Signs: HTN, edema, changes in urine color, nausea, vomiting and
headaches.
ANCA: anti-neutrophil
cytoplastic antibody
2/1/2021
. STM4201 MNT for renal disorders 7
The Most Common Kidney Diseases
Nephrotic Syndrome- A set of symptoms including
proteinuria, edema and hyperlipidemia.
2/1/2021
. STM4201 MNT for renal disorders 8
The Most Common Kidney Diseases
Acute Renal Failure - Sudden kidney failure caused by
blood loss, drugs or poisons.
– If the kidneys are not seriously damaged, acute renal failure may
be reversed.
2/1/2021
. STM4201 MNT for renal disorders 9
Hematological Indicators
i) Hemoglobin: ↓ due to lack of erythropoietin (EPO),
produced by the kidney; pts receive synthetic EPO tx
(Epogen)
– May have anemia of chronic disease
ii) Ferritin : may be indicator of iron overload; ↑ ferritin may
mean EPO resistance (deficient production of erythropoietin)
2/1/2021
. STM4201 MNT for renal disorders 10
Glomerular Filtration Rate (GFR)
Best index of kidney function
Used to establish stage of CKD
GFR is the amount of filtrate formed per minute based on
total surface area available for filtration (number of
functioning glomeruli)
Can be determined using injected isotope (inulin)
measurement in urine
Can be calculated from serum creatinine using standard
equations
2/1/2021
. STM4201 MNT for renal disorders 11
Medical Nutrition Therapy (MNT)
for Chronic Kidney Disease
(CKD)
◼ Protein-energy
malnutrition is a
common complication of
CKD (Kopple et al, 2000)
◼ Control of HbA1c
4
The Most Common Cancer In Malaysia
4
Gender Differences in Sites of Cancer
Introduction
Cancer
• Abnormal cell division
and reproduction that
can spread throughout
the body
• Three stages of
carcinogenesis:
i) Initiation (initial stage)
ii)Promotion (initiated cells
are activated)
iii)Progression, i.e
metastasis
Nutrition & carcinogenesis
Carcinogen
• Physical, chemical or viral agents that
induces cancer
• Diet contain both:
I. Inhibitor – antioxidant (vitamin C,
vitamin A and the carotenoids, vitamin
E, selenium, zinc) & phytochemicals
II. Enhancer of carcinogenesis - saturated
fat in red meat, alcohol, smoked,
grilled & preserved foods.
Nutrition & carcinogenesis
Fat
Red meat, dietary fat and milk intake should be minimised as they
appear to increase the risk of prostate cancer. Fruit and vegetables and
polyphenols may be preventive in prostate cancer, but further studies are
needed to draw more solid conclusions and to clarify their role in
patients with an established diagnosis of prostate cancer. Selenium and
vitamin supplements cannot be advocated for the prevention of prostate
cancer and indeed higher doses may be associated with a worse
prognosis. There is no specific evidence regarding benefits of probiotics
or prebiotics in prostate cancer.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Nutrition & carcinogenesis
Metabolic
Obesity syndrome
↑ circulating levels
of insulin-like growth
factor-1 (IGF-1)
Age Hyperglycemia
IGF-1
• Secretion ↑ when insulin level ↑
• Stimulate the growth of cancer cells.
MNT for
Cancer Prevention
Chemoprevention
• Defined as the use of drugs, vitamins, or other
agents to reduce the risk of, or delay the
development or recurrence of cancer (NIH, NCI, 2015).
• Coffee and Tea: contains various antioxidant and
phenolic compounds - have anticancer properties.
• Fruits and Vegetables: contains anticarcinogenic
agents - antioxidants such as vitamins C and E,
selenium, and phytochemicals.
• Soy and Phytoestrogens: contains phytoestrogens
and isoflavones - modest amounts of soy protect
against breast cancer (ACS, 2012)
Cancer Prevention Recommendations
MNT for
Cancer Treatment
Nutritional Issues in Cancer Care
Depletion of nutrient stores, anorexia, weight loss and poor nutritional
status are found in many individuals at the time of diagnosis (Goldman
et al. 2006).
9
Impediments to Adequate Nutrition
1. Tumor-Induced Effects on Nutrition Status
• Tumor-induced pathophysiological changes alter
the macronutrient metabolic pathways leading to
increased protein catabolism, muscle protein
degradation and elevated lipid oxidation.
• The type or stage of cancer may affect energy
metabolism
2. Treatment-Induced Effects on Nutrition Status
• Side effects of cancer treatments vary among
patients, depending on the type, length, and
dose of treatments and the type of cancer being
treated.
Cancer Treatment and
Nutritional Implications
Chemotherapy
– Anemia, fatigue, nausea, vomiting,
loss of appetite, mucositis, changes
in taste and small, xerostomia,
dysphagia, diarrhea, constipation
Immunotherapy
– Fatigue, chills, fever, flu-like
symptoms, decreased food intake
Radiation therapy
– Fatigue, loss of appetite, skin
changes, and site-specific effects
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Cancer Treatment and Nutritional Implications–cont’d
Hematopoietic stem cell transplantation
– Nausea, vomiting, anorexia, dysgeusia, stomatitis, oral
and esophageal mucositis, fatigue, and diarrhea
– Dietary precautions with neutropenia
– Graft versus host disease (GVHD): immunologic
reaction of allogeneic donor cells (graft) reacting
against the pt (host) tissue
– Sinusoidal obstructive syndrome (SOS): occlusion of
small hepatic venules caused by hepatotoxins &
radiation therapy/ chemo
Surgery
– Fatigue, pain, loss of appetite
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Basic principles of nutrition
in cancer patients
1. Malnutrition (protein-calorie malnutrition)
2. Significant weight loss
3. Anorexia
4. Cachexia
• Progressive wasting syndrome evidenced by
weakness and a marked and progressive loss
of body weight, fat, and muscle
5. Sarcopenia (severe muscle depletion)
Cancer Cachexia
Progressive wt loss
Anorexia
Generalized wasting and weakness
Immunosuppression
Altered BMR
Abnormalities in fluid and energy
metabolism
Mediated via cytokines, including
TNF-a and TNF-b, cachectin, IL-1,
IL-6, and IFN-a
https://www.youtube.com/watch?v=sqWTt4k3PAI
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
BMI nutritional status by diagnoses.*Others included multiple myeloma, sarcoma, leukemia,
thymoma, meningioma, plasmocytoma, melanoma, cancer of the bladder, kidney, or pancreas, or
occult primary tumor metastases.
11
Nutrition Screening
and NCP Flowchart
14
MST
SGA &
PGSGA
15
Adapted from: The American Society for Parenteral and Enteral Nutrition (ASPEN) 2011
Nutrition Screening
16
Evidence Statement of Nutrition Screening
Evidence Statement Grade References
MST is an effective and validated B DAA, 2006
screening tool for identifying risk of COSA, 2011
malnutrition in cancer patients
Malnutrition screening should be B COSA, 2011
undertaken in all patients at diagnosis to
identify those at nutritional risk and
should be repeated at intervals through
each stage of treatment (e.g. surgery,
radiotherapy / chemotherapy and post
treatment). If identified at high risk, do
refer to the dietitian for early intervention.
All HNC patients receiving radiation A
therapy should be referred to dietitian for COSA, 2011
nutrition support intervention
17
Malnutrition Screening Tool (MST)
1. Have you lost weight recently without trying?
If no (0)
If unsure( 2)
If yes, how much weight (kg) have you lost?
0.5–5.0 ( 1)
>5.0–10.0 (2)
>10.0–15.0 (3)
>15.0 (4)
2. Have you been eating poorly because of a decreased appetite?
No ( 0)
Yes (1)
If score 0 or 1 not at risk of
malnutrition
≥ 2 at risk of malnutrition
Ferguson M, Bauer J, Banks M, Capra S. 1999. Development
of a valid and reliable malnutrition screening tool for adult
acute hospital patients. Nutrition. 15: 458–464. 18
Nutrition Assessment
19
Nutrition Assessment Criteria
(i) Tools/ Instruments
- The Scored Patient Generated–Subjective Global Assessment
(PG-SGA) - gold standard (Leuenberger et al., 2010)
- Subjective Global Assessment (SGA)
23
Protein Requirement
Table 4: Estimating Daily Protein Needs in Cancer Patients
29
FLUID &
MACRONUTRIENT
REQUIREMENT
27
Table 5: Estimating Fluid
Needs in Cancer Patients
16-30, active 40
31-55 35
56-75 30
76 or older 25
These recommendations are just for maintenance needs. Fluid
requirement in fluid overload or dehydration patients need to
be adjusted.
Source: ADA, 2000
30
Algorithm of Nutrition
Support for Cancer Patients
31
32
Ref: ESPEN, 2006; FESEO, 2008
Nutrition Intervention
and Recommendation
35
Diet and Counseling
Recommendation Grade References
38
Diet and Counseling
Recommendation Grade References
39
Dietary Guidelines for Immunosuppressed
Patients – Neutropenic Diet
48
Nutrition Education
& Counselling
51
Nutrition Intervention Strategies for
Patients with Cancer
Nutrition Intervention Strategies for
Patients with Cancer
Nutrition Intervention Strategies for
Patients with Cancer
Nutrition Intervention Strategies for
Patients with Cancer
Nutrition Intervention Strategies for
Patients with Cancer
Complementary and Alternative Therapies
Whole medical systems
– Traditional Chinese Medicine, ayurvedic medicine, homeopathy,
naturopathy
Mind-body interventions
– Mindfulness, meditation
Biologically based therapies
– Botanicals, dietary supplements, vitamins, minerals
Manipulative and body-based methods
– Massage, yoga, reflexology, prayer
Energy therapies
– Veritable and measurable – sound, light, energy
– Putative such as biofields
Islamic medical approach
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
Physical Activity
& Cancer
53
…exercise after the diagnosis of breast cancer improves mortality,
morbidity, health related quality of life, fatigue, physical functioning,
muscle strength, and emotional wellbeing.
Elsevier items and derived items © 2008, 2004 by Saunders, an imprint of Elsevier Inc.
54
54
MNT for
Cancer Survivor
• Key recommendations:
➢ Maintain healthy weight
➢ Practice healthy eating & be physically
active
53
Nutrition Support:
Enteral and Parenteral Nutrition
Nutrition Support
Definition: the provision of nutrients to pts
who cannot meet their nutritional requirements
by eating standard diets
Goals:
➢Prevent or treat macro µnutrient deficiencies
➢Provide doses of nutrients compatible with existing
metabolism
➢Avoid or manage complications related to the
technique of nutritional delivery
➢Improve pts’ outcomes
Enteral Nutrition (EN)
Long term
Nutrition Assessment
To identify the pts with pre-existing
malnutrition or with risk for malnutrition
Conditions That Require Other
Nutrition Support
Enteral Parenteral
—Impaired ingestion —Gastrointestinal
—Inability to consume incompetency
adequate nutrition —Hypermetabolic
orally state with poor
—Impaired digestion, enteral tolerance or
absorption, metabolism accessibility
—Severe wasting or
depressed growth
Conditions That Often Require Nutritional Support
Conditions That Often Require Nutritional Support –
cont’d
EN vs. PN
1. Applicable
2. Site placement
3. Formula selection
4. Nutritional/medical requirements
5. Rate and method of delivery
6. Tolerance
Formula Selection
The suitability of a feeding formula should be evaluated
based on
Functional status of GI tract
Physical characteristics of formula (osmolality, fiber
content, caloric density, viscosity)
Macronutrient ratios
Digestion and absorption capability of patient
Specific metabolic needs
Contribution of the feeding to fluid and electrolyte
needs or restriction
Cost effectiveness
Factors to Consider When Choosing an Enteral
Formula
Types of EN Formula
Contain whole proteins, complex CHO and long chain triglycerides
(nutrients are intact / have not been broken down)
/ specialized formula
Enteral Access: Clinical Considerations
https://www.youtube.com/w
atch?v=yBzy3tHOps0
Administration: Feeding Rate
Continuous method = slow rate of 50 to
150 ml/hr for 12 to 24 hours
• Touch contamination
• Formula manipulation
• Prolonged hang time
• Unsafe storage
• Reusing feeding sets
Gastrointestinal complications
• Diarrhea
• Constipation
• Nausea and vomiting
• Abdominal distention, bloating, cramping, gas
Diarrhea – factors UNRELATED to
tube feeding
Diarrhea – factors RELATED to
tube feeding
Consideration of Physical Properties
of Enteral Formulas
Residue
Viscosity
—Size of tube is important
Osmolality (solute/solution): consider protein
source
—Intact (do not affect osmolality)—soy
isolates; sodium or calcium casein;
lactalbumin
—Hydrolyzed (more particles)—peptides or
free amino acids
Lower Osmolality
Large (intact) proteins
Large starch molecules
Higher Osmolality
Hydrolyzed protein or amino acids
Disaccharides
Complications of Enteral Feeding
Metabolic complications / Refeeding
syndrome
• Dehydration / overhydration
• Hyperglycemia
• Hyper/hyponatraemia
• Hyper/hypophosphataemia
• Hyper/hypokalaemia
• Hypercapnia (excessive CHO load; overfeeding)
Mechanical complications
• Aspiration pneumonia
• Nasal, esophageal and mucosal irritation and
erosion
• Irritation and leakage at stoma site
• Tube clogging
Refeeding
Syndrome • Neuro-muscular
dysfunction
https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2440847/ • Cardiac
arrhythmia
Costly
Acid-base abnormalities
Refeeding Syndrome
Calculating Nutrient Needs
Avoid excess kcal (> 40 kcal/kg)
Adults
kcal/kg BW
Obese—use desired BMI range or an
adjusted factor
Adjusted Body Weight
Adjusted IBW for obesity
Female:
([actual weight – IBW] x 0.32) + IBW
Male:
([actual weight – IBW] x 0.38) + IBW
Protein Requirements
1.2 to 1.5 g protein/kg IBW
mild or moderate stress
Carbohydrate Requirements
Max. 0.36 g/kg BW/hr
Lipid Requirements
4% to 10% kcals given as lipid meets EFA
requirements
Stop slowly
(reduce rate by half every 1 to 2 hrs)
Monitoring and Complications
Infection
Catheter care
Monitor
Weight
(daily)
Blood
Daily
Electrolytes (Na+, K+, Cl-)
Glucose
Acid-base status
Monitor—cont’d
Blood
Twice/week
Ammonia
Weekly
Hgb
Triglycerides
Monitor—cont’d
Other:
USPSTF
Screen all ≥ 18 yrs for obesity.
AHA/TOS 2013:
BMI at annual visits or more frequently. ( level E )
Managment
Patient centered Plan:
State His weight loss goals
Addressing barriers to change
Developing strategies to maintain long-term lifestyle
changes.
Management :
Behavioral Interventions
Improving nutrition
Increasing physical activity
Maintenance !!
Management:
Behavioral interventions and Diet should be initiated
in patients who are obese.
Motivational interviewing
1-2 sessions /months .
Behavioural interventions
Self-monitoring of behaviour and progress
Stimulus control
Goal setting
Slowing rate of eating
Ensuring social support
Problem solving Skills
modifying thoughts
Reinforcement of changes
Relapse prevention Skills
Strategies for dealing with weight regain.
Motivational Interviewing Techniques
Motivational Interviewing Techniques
Dietary Approaches :
Which Dietary Approaches Have Been Shown to Be Most
Effective for Weight Loss?
Adherence to calorie reduction .
Decrease inactivity.
To prevent obesity: 45–60 min/day of moderate-
intensity activity particularly if they do not reduce
their energy intake.
AAFP:
Update on office based strategies for the management of obesity.
Diagnosis and management of obesity guideline 2013